Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apogenix, Black Diamond, Chi-Med, Foresee, Hemoshear, Larimar, Momenta, Nabriva, Protara, Realta.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Color, Labcorp, Rapid Medical, Stratus Medical, Zebra Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Beigene, Can-Fite, Carisma, Celltrion, Checkmate, Diffusion, Eton, Generex, Gilead, Kite, Kyowa, Merus, Neoimmunetech, Ocugen, Oculis, Pharmacyte, Scpharmaceuticals, Solid.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adaptimmune, Astrazeneca, Biomarin, Blueprint, Galapagos, Gilead, Heron, Insmed, Kyowa Kirin, Miragen, Myokardia, Novartis, Oncoceutics, Sarepta, Vistagen.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Beckman Coulter, Caption Health, Inspiremd, Nobilis, Palliare, Thermo Fisher.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adial, Cymabay, Elsalys, Inotrem, Milestone, Neumentum, Vita.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Becton Dickinson, Canon Medical, Cerapedics, Integra, X-Nav Technologies.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aurinia, AGTC, Jazz, MC2, Redhill.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Astellas, Beigene, Deciphera, Generex, Immuron, IMV, Puma, Redhill, Shanghai Fosun, Sorrento, Specialised, Tetra.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Channel Medsystems, Lifesignals, OralDNA Labs, Paige.